A group of Massachusetts-based researchers say they believe omicron could already account for about 15% of COVID-19 cases in some parts of the U.S.
Author: Elizabeth Weise and Karen Weintraub, USA TODAY
FDA panel supports J&J COVID-19 vaccine booster shot for all Americans who got a first dose
In an unanimous vote, a federal advisory committee supported boosters of the J&J vaccine for all adults at least two months after a single shot.
FDA panel approves Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk
There isn’t yet sufficient evidence to support boosters for people under 65, the FDA Vaccines and Related Biological Products Advisory Committee said.
Moderna says its COVID vaccine found to be 100% effective in children 12 to 17 two weeks after second dose
The Moderna vaccine was 93% effective against COVID-19 in teenagers aged 12 to 17 after the first dose and 100% two weeks after the second dose.
Coronavirus variant that first appeared in India arrives in the US. Here’s what to know.
Experts say the India variant probably will not cause great harm in the U.S. because of high vaccination rates, but they are watching it.
Pause on Johnson & Johnson COVID vaccine in US lifted by FDA, use to resume
The pause on the one-dose J&J COVID vaccine will be lifted and distribution will resume in the U.S., FDA officials said Friday night.
Vaccine passports should be free, private and secure, White House says. But who will be issuing them?
Israel has a “green card” to prove that people have been vaccinated and other countries are contemplating requiring proof of vaccination for entry.
A COVID-19 vaccine life cycle: from DNA to doses
Making a vaccine against the coronavirus is a complicated, months-long process. Pfizer is working to get it done faster. It still takes time.
Where did COVID-19 come from?
As the U.S. marks one year since its first case, questions remain about the origin of the coronavirus that causes the disease. The answers matter.
Key committee endorses Pfizer’s COVID-19 vaccine, paving way for clearance by FDA and vaccinations in US to begin
The endorsement paves the way for a final decision by the FDA, and mass vaccinations to begin within days.